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The ncuropcptidcs, ubstance 1’ and ncurokinin A, 
arc synthcsizarl f om a family of pwursor polypcpcitlcs 
cncodcd by the prcprotachykinin A gcnc [ 11, In rilt d 
bovine tissues, the largest form of PP’I’ mHNA (&PP’T) 
contains regions dcrivcrl from all 7 cxotis of the cor- 
responding gcnc, with scqucnccs in cxon 3 encoding 
substance P and scqucnces in coon 6 encoding 
ncurokinin A. 
Altcrnativcly spliced forms lacking cithcr cxon 6 (LY- 
PPT) or cxon 4 (y-PPT) arc also found [Z&5]: in all rat 
tissues so far examined, -/-PPT is the most abundant 
form of PPT mRNA [Ml. WC report hcrc the 
charactcrisation of PPT splicing products in rat DRG, 
using the polymerasc hain reaction VCR). WC have 
idsntificd a novel and rclativcly abundant splicing 
variant of PPT mRNA lacking both cxons 4 and 6 (6” 
PPT), which encodes a predicted polypeptide contain- 
ing the sequence of substance P but not of neurokinin 
A. The expected processing products of rat 6-PPT in- 
clude a C-terminal peptide of 22 amino acids unique to 
the &PPT precursor. 
The oli~antlclcoiitlcs (synthcriscd by Oswcl DNA VW ice, Univcr+i. 
ty of Edinburgh) usrtl for PCK WI’C 5’.A(‘i/‘rh’l”l’CAA(:AT~jA/~A. 
A’i’CC.“f’COTCi-3’ (Oligo 1: corrcspondirte to il rspiort ia csw 2 which 
inclurlcs the irriliator sodoll A’TCj of riot 1’1’7’ mKNA, with illl E’&IKI 
rcktriction sils iniroduccd nt 1lilScS 2-7) nncl 5’ .‘I’ci(;~I’~:c:‘I’c~i~~(;. 
CiACACAC;A’TCiOAGA~‘.3’ (Uligo 2: C~lllplClllCllIilr~ 10 II region in 
cxon 7 of rat PP’l mKFlA imrncdi;ttcly 3 ’ IO the termination cudon, 
with il fjcr~H1 restriction site introduced nt tmcs 2-7). Kcnctions ~1~~ 
taincd 10 ng singlc+trnndcd cl3NA, 200 pmol of each 
oligonuclcotidc, 200 ,cM dATP, dc”I’I’, dC’Tt’ :cntl dn’l’ nnd 2.9 
units Ampiitnq DNA polymcrasc in 100 pl P i R burfcr (Perkin-13lmcr 
Cct~), JO CYCICS of PCK (45 s at 94’C, 4S s at .50°C, 2 min at 72’C) 
wrc performed md polymcrisntion HW continued for :I further 5 rnirl 
al 72°C at the end of the last cycle. PCR products wcrc nnnlyscd by 
clc~trophorcsis on 2% agnrosc or Soi0 polyacrylnmids gels. 
2.3. Clotfirtg cm1 sequotce atrulysis 
2. EXPEKlMENTAL 
PCR products were clcnvcd with BUUIHI and f?coRI and inscrtcd 
bctwecn the corresponding restriction sites of the plasmid pGrm3 
(&omega). Clones wcrc scqucaced on both strands by the method of 
Sangcr et al. [IO] after subcloning into bacteriophages Ml3 mplR and 
Ml3 mpl’). 
2.1, cDNA synthesis 
3. RESULTS 
DRG were dissected from adult male rats @iam Wistnr; 200450 8) 
and RNA was isolated by the gunnidinium thiocyanatc/cacsium 
3.1. Characterisntion of PPT splicing products in rat 
DRG 
Co~responde~tce ~c/&ss: A.J. Harmar, MRC Brain Metabolism 
Unit, Royal Edinburgh Hospital, Morningside Park, Edinburgh, 
EHlO SHF, UK 
Abbrevistions: cDNA, complementary DNA; mRNA, messenger 
RNA; PCR, polymerafs chain reaction 
The nucleotide sequence presented here has been submitted to the 
EMBL/GenBank database under the accession number no. X56306 
To investigate the forms of PPT mRNA in rat DRG, 
cDNA synthesised from DRG poly(A)* RNA was 
amplified by PCR and the products analysed by 
polyacrylamidc gel elcctrophoresis (Fig. 1). The Pc’R 
products were resolved into three bands of approx- 
imately 450, 400 and 350 bp. The size of the largest 
cDNA was close to that predicted for the PCH product 
of P-PPT (454 bp) whereas the band at -400 bp was 
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3 m 2. ~&FltiJiC’~tiWI artd sct~uo~cc oj’cr novd PPT cBNA 
To cstnblish whcthcr the PCR product of *-,350 bp 
rcprcscntcd a novel splicing variant, PCR amplified 
cDNA was cloned into the vector pGc1113 and clones 
were characlcrised by restriction analysis. Clones wcrc 
classifi.cd by insert size and by the presence or absence 
of a restriction site for BWI, which restricts PPT cDNA 
once in exon 6 and therefore cleaves p- and y-FPT but 
not c+PPT. Clones containing inserts of 4 size classes 
were obtained. The majority of clones contained inserts 
with the properties predicted for y-PPT (inserts of 
-410 bp with an internal DrrrI site). In addition, clones 
with the properties expected of P-PPT (insert -450 bp, 
internal DwI site), CL+PPT (insert -400 bp, no BraI 
site) and the proposed 6-PPT variant (insert - 350 bp, 
no DrcrI site) were found at. a lower frequency. 
Representative clones of each of the four size classes 
were sequenced (Fig. 2): clones corresponding to W, p- 
and y-PPT were identified, together with clones with 
the structure predicted for &PPT. The sequences of W, 
,& and y-PPT were identical to those reported previous- 
ly [4,ii], whilst the &PPT clones contained sequences 
corresponding to exons 2, 3, 5 and 9. The sequence of 
-1. I~Isc.‘cJsslobi 
In bovine tissues, the splicing of PPT mRNA has 
been rcportsd to differ bctwccn tissues, with @-PPT 
predominating in nervous tissue and a-PPT 
predominating in thyroid and gut [3]. In contrast, T- 
PPT is the most abundant form of PPT rnRNA in the 
rat, and the splicing pattern of’ PPTgenc transcripts has 
been rcportcd to be rclntivcly constant in all tissues 
studied [5-g], ‘l’hcsc data were obtained from nuclcasc 
protection assays [121 usiug cithcr end-labcllcd cDNA 
probes (which would not detect &PDT mRNA) or 
uniformly-labcllsd cRNA probes (whore the only in- 
dication of the prcscncc of 8-PPT would be a 45 bp 
RNA fragment hat could easily bc overlooked), In the 
light of our findings, the tissue distribution of the splic- 
ing variants of PPT mRNA and the possibility that 
splicing can be regulated by physiological stimuli 
should be reexamined. 
The products of post-translational processing of the 
&PPT polypeptide may be predicted on the basis of 
previous tudies [13,14]. Two polypeptides arc likely to 
be produced in addition to substance P; a N-flanking 
peptide of 39 amino acids encoded by all four splicing 
variants of PPT mRNA [14] and a C-flanking peptide 
of 22 amino acids (amino acids 72-93 of the 6-PPT 
polypeptide) which is encoded uniquely by B-PPT 
mRNA. The findings of McGregor et al. [13] may pro- 
vide some evidence for the expression of the B-PPT 
polypeptid,e in rat tissues. In chromatographic studies 
of peptiries immunoreactive with antisera to the C- 
terminus of the PPT polypeptide they found evidence 
for the, presence of the predicted C-flanking peptide of 
@-PPT but not for the corresponding processing pro- 
duct of a-WT. An additional peptide detected in these 
23 
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Beta PPT CAAC ATG AAA ATC CTC GTG GCG GTG GCG GTC TTT TTT CTC OTT TCC ACT CAA CTG TTT GCA GAG 64 
Alpha PPT CAAC ATG AAA ATC CTC GTG GCG GTG GCG GTC TTT TTT CTC GTT TCC ACT CAA CTG TTT GCA GAG 64 
Gamma PPT CAAC ATG AAA ATC CTC GTG GCG GTG GCG GTC TTT TTT CTC GTT TCC ACT CAR CTG TTT GCA GAG 64 
Delta PPT CAAC ATG AAA ATC CTC GTG GCG GTG GCG GTC TTT TTT CTC GTT TCC ACT CAA CTG TTT GCA GAG 64 
t4et LYS 11~ Leu Val Ala Val ala Val Pha Phe Lsu Val Ser Thr Gin Leu Phe Ala GJ.u 
Beta PPT GAA ATC GGT GCC AAC GAT OAT CTA RAT TAT TGG TCC GAC TGG TCC GAC AGT GAC CAA ATC 124 
Alpha PPT GAA ATC GGT GCC AAC GAT GAT CTA AAT TAT TGG TCC GAC TGG TCC GAC AGT GAC WA ATC 124 
Gamma PPT GAA ATC GGT GCC AAC GAT GAT CTA AAT TAT TGG TCC GAC TGG TCC GAC AGT GAC CAA ATC 124 
Delta PPT G&A ATC GGT GCC ARC GAT GAT CTA AAT TAT TGG TCC GAC TGG TCC GAC AGT GAC CAA ATC 124 
GLu Ile Gly Ala Asn Asp Asp Leu Asn Tyr Trp Ser Asp Trp Ser Asp Ser Asp Gin Ile 
Beta PPT AAG GAG GCA ATG CCG GAG CCC TTT GAG CAT CTT CTT CAG AGA ATC CCC CGA AGA CCC AAG 184 
Alpha PPT AAG GAG GCA ATG CCG GAG CCC TTT GAG CAT CTT CTT CAG AGA ATC CCC CGA AGA CCC AAG 184 
Gamma PPT AA0 GAG GCA ATG CCG GAG CCC TTT GAG CAT CTT CTT CAG AGA ATC GCC CGA AGA'.,Cb AAG 184 
Delta PPT AhG GAG GCA ATG CCG GAG CCC TTT GAG CAT CTT CTT CAG AGA ATC GCC CGA,AGA CCC AAG 164 
Lys Glu Ala Met Pro Glu Pro Pha Glu His Lcu Leu Gin Arg Ile Ala Arg AW_bz?-LI.us 
Beta PPT CCT CAG CAG TTC TTT GGA TTA ATG GGC AAA CGG GAT GCT GAT TCC TCA ATT GAA AAA CAA 244 
Alpha PPT CCT CAG CAG TTC TTT GGA TTA ATG GGC AAA CGG GAT GCT GAT TCC TCA ATT GA.4 ABA CAA 244 
Gamma PPT CCT CAG CAG TTC TTT GGA TTA ATG GGC AAA CGG GAT GCT G.. .., ,.. . . . . . . . . . . . . 224 
Delta PPT CCT CAG CAG TTC TTT GGA TTA ATG GGC AAR CGG GAT GCT G.. . . . . . . .I. . . . . . . . . . 224 
pro ~ln Oln Phe !i?&._G& LMI k&& Gly Lys Acg Asp Ala G 
Beta PPT GTG GCC CTG TTA AAG GCT CTT TAT GGG CAT GGT CAG ATC TCT CAC AAA AGG CAT AAA ACA 304 
Alpha PFT GTG GCC CTG TTA AAG GCT CTT TAT GGG CAT GGT CAG ATC TCT CAC AAA A.. . . . . . . . . . 293 
Gamma PPT . . . .., . . . . . . . . . .,. . . . . . . .GG CAT GGT CAG ATC TCT CAC AAA WG CAT AAA ACA 259 
Delta PPT .I. . . . . . . . . . . . . .*. .." . . . .GG CAT GGT CAG ATC TCT CAC AAA A.. . . . . . . . . . 248 
ly His Gly Gln Ile Se.? His Lys M 
Beta PPT GAT TCC TTT GTT GGA CTA ATG GGC AAA AGR GCT TTA AAT TCT GTG GCT TAT GAA AGA AGC 364 
Alpha PPT . . . . . . . . . ..* ..o .*. . . . *.. . . . . . . ..* . . . .., ..I .TG GCT TAT GAA AGA AGC 310 
Gamma PPT GAT TCC TTT GTT GGA CTA ATG GGC AAA AGA GCT TTA AAT TCT GTG GCT TAT GAA AGA AGC 319 
Delta PPT *.* ..* . . . .I. . . . .,. . . . .., ,.. . . . ,.. . . . ,.. . . . .TG GCT TAT GAA AGA AGC 265 
et Ala Tyr Glu Arg Ser 
Beta PPT GCA ATG CAG AAC TAC GAA AGA AGG CGT AAA TAAACCCTGTAACGCACTATCTATTCATCTCCATCTGTGTCCGCGAG 441 
Alpha PPT GCA ATG CAG AAC TAC GAA AGA AGG CGT AAA TARACCCTGTAACGCACTATCTATTCATCTCCATCTGTGTCCGCGAG 38; 
Gamma PPT GCA ATG CAG AAC TAC GAA AGA AGG CGT AAA TAAACCCTGTAACGCACTATCTATTCATCTCCATCTGTGTCCGCGAG 396 
Delta PPT GCA ATG CAG AAC TAC GAA AGA AGG CGT AAA TAAACCCTGTAACGCACTATCTATTCATCTCCATCTGTGTCCGCGAG 342 
Ala Met Gin Asn Tyr Glu Arg Arg Arg Lys 
Fig. 2. Nucleotide sequences of cDNA inserts coding for rat (Y-, 6-, y- and 6-PPT. The predicted amino acid sequence of rat &PPT is indicated 
below the aligned cDNA sequences: the sequence of substance P is underlined. 
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